Updates to Medicare's Quality Payment Program That May Impact You

被引:3
作者
Cardona, Diana M. [1 ]
Peditto, Stephanie [2 ]
Singh, Loveleen [2 ]
Black-Schaffer, Stephen [3 ,4 ]
机构
[1] Duke Univ, Dept Pathol, Med Ctr, Box 3712, Durham, NC 27710 USA
[2] Coll Amer Pathologists, Advocacy Div, Washington, DC USA
[3] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
[4] Harvard Med Sch, Boston, MA 02115 USA
关键词
D O I
10.5858/arpa.2019-0376-RA
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Context.-Within Medicare's Quality Payment Program, and more specifically the Merit-based Incentive Payment System, pathologists stand to potentially lose or gain approximately $2 billion during the initial 7 years of the program. If you or your group provides services to Medicare beneficiaries, you will likely need to comply with the program. Objective.-To avoid potential reductions in Medicare reimbursement, pathologists need to understand the requirements of these new payment programs. Data Sources.-Each year the Centers for Medicare & Medicaid Services publish a Final Rule detailing the program requirements and updates. 2020 marks the fourth reporting year for the Merit-based Incentive Payment System. Performance this year will impact 2022 Medicare Part B distributions by up to +/- 9%. Conclusions.-By staying up to date with the ever-evolving Merit-based Incentive Payment System requirements, pathologists will be better equipped to successfully comply with this relatively new payment system, reduce the burden of participating, understand the reporting differences of the various performance categories, and thereby be able to maximize their scoring and incentive potential.
引用
收藏
页码:679 / 685
页数:7
相关论文
共 3 条
[1]  
[Anonymous], 2020 PATH QUAL MEAS
[2]  
[Anonymous], 2017 QUAL PAYM PROGR
[3]  
Centers for Medicare & Medicaid Services, 2019 MER BAS INC PAY